APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatocyte Growth Factor

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Selected research

Market Structure

Global Hepatocyte Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025188 pages

Choose your research edition.

Industry ResearchHepatocyte Growth Factor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatocyte Growth Factor Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hepatocyte Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatocyte Growth Factor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatocyte Growth Factor Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.

This report provides an overview of the global Hepatocyte Growth Factor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hepatocyte Growth Factor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepatocyte Growth Factor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hepatocyte Growth Factor market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepatocyte Growth Factor Segment by Company

ViroMed

AnGes MG

M3 Biotechnology

AVEO Pharmaceuticals

Molecular Partners

Yooyoung Pharm

F-star

Galaxy Biotech

Kringle Pharma

Hepatocyte Growth Factor Segment by Type

Phase III (Ongoing)

Phase II (Approved)

Phase II (Ongoing)

Phase 1

Preclinical

Hepatocyte Growth Factor Segment by Application

Oncology

Cardiovascular

Central Nervous System

Hematological Disorders

Others

Hepatocyte Growth Factor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatocyte Growth Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatocyte Growth Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatocyte Growth Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hepatocyte Growth Factor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatocyte Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hepatocyte Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hepatocyte Growth Factor Industry Trends Table 2. Hepatocyte Growth Factor Industry Drivers Table 3. Hepatocyte Growth Factor Industry Opportunities and Challenges Table 4. Hepatocyte Growth Factor Industry Restraints Table 5. Global Hepatocyte Growth Factor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hepatocyte Growth Factor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hepatocyte Growth Factor Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hepatocyte Growth Factor Sales Market Share by Manufacturers Table 9. Global Hepatocyte Growth Factor Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Hepatocyte Growth Factor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hepatocyte Growth Factor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hepatocyte Growth Factor Manufacturers, Product Type & Application Table 13. Global Hepatocyte Growth Factor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hepatocyte Growth Factor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Phase III (Ongoing) Table 17. Major Manufacturers of Phase II (Approved) Table 18. Major Manufacturers of Phase II (Ongoing) Table 19. Major Manufacturers of Phase 1 Table 20. Major Manufacturers of Preclinical Table 21. Global Hepatocyte Growth Factor Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Hepatocyte Growth Factor Sales by Type (2021-2026) & (K Units) Table 23. Global Hepatocyte Growth Factor Sales by Type (2027-2032) & (K Units) Table 24. Global Hepatocyte Growth Factor Sales Market Share by Type (2021-2026) Table 25. Global Hepatocyte Growth Factor Sales Market Share by Type (2027-2032) Table 26. Global Hepatocyte Growth Factor Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Hepatocyte Growth Factor Revenue by Type (2021-2026) & (K Units) Table 28. Global Hepatocyte Growth Factor Revenue by Type (2027-2032) & (K Units) Table 29. Global Hepatocyte Growth Factor Revenue Market Share by Type (2021-2026) Table 30. Global Hepatocyte Growth Factor Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Oncology Table 32. Major Manufacturers of Cardiovascular Table 33. Major Manufacturers of Central Nervous System Table 34. Major Manufacturers of Hematological Disorders Table 35. Major Manufacturers of Others Table 36. Global Hepatocyte Growth Factor Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hepatocyte Growth Factor Sales by Application (2021-2026) & (K Units) Table 38. Global Hepatocyte Growth Factor Sales by Application (2027-2032) & (K Units) Table 39. Global Hepatocyte Growth Factor Sales Market Share by Application (2021-2026) Table 40. Global Hepatocyte Growth Factor Sales Market Share by Application (2027-2032) Table 41. Global Hepatocyte Growth Factor Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hepatocyte Growth Factor Revenue by Application (2021-2026) & (K Units) Table 43. Global Hepatocyte Growth Factor Revenue by Application (2027-2032) & (K Units) Table 44. Global Hepatocyte Growth Factor Revenue Market Share by Application (2021-2026) Table 45. Global Hepatocyte Growth Factor Revenue Market Share by Application (2027-2032) Table 46. Global Hepatocyte Growth Factor Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Hepatocyte Growth Factor Sales by Region (2021-2026) & (K Units) Table 48. Global Hepatocyte Growth Factor Sales Market Share by Region (2021-2026) Table 49. Global Hepatocyte Growth Factor Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Hepatocyte Growth Factor Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 53. North America Hepatocyte Growth Factor Sales by Country (2027-2032) & (K Units) Table 54. Europe Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 56. Europe Hepatocyte Growth Factor Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Hepatocyte Growth Factor Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Hepatocyte Growth Factor Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Hepatocyte Growth Factor Sales by Country (2027-2032) & (K Units) Table 63. Global Hepatocyte Growth Factor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Hepatocyte Growth Factor Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Hepatocyte Growth Factor Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Hepatocyte Growth Factor Revenue Market Share by Region (2021-2026) Table 67. Global Hepatocyte Growth Factor Revenue Market Share by Region (2027-2032) Table 68. ViroMed Company Information Table 69. ViroMed Business Overview Table 70. ViroMed Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. ViroMed Hepatocyte Growth Factor Product Portfolio Table 72. ViroMed Recent Development Table 73. AnGes MG Company Information Table 74. AnGes MG Business Overview Table 75. AnGes MG Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AnGes MG Hepatocyte Growth Factor Product Portfolio Table 77. AnGes MG Recent Development Table 78. M3 Biotechnology Company Information Table 79. M3 Biotechnology Business Overview Table 80. M3 Biotechnology Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. M3 Biotechnology Hepatocyte Growth Factor Product Portfolio Table 82. M3 Biotechnology Recent Development Table 83. AVEO Pharmaceuticals Company Information Table 84. AVEO Pharmaceuticals Business Overview Table 85. AVEO Pharmaceuticals Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AVEO Pharmaceuticals Hepatocyte Growth Factor Product Portfolio Table 87. AVEO Pharmaceuticals Recent Development Table 88. Molecular Partners Company Information Table 89. Molecular Partners Business Overview Table 90. Molecular Partners Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Molecular Partners Hepatocyte Growth Factor Product Portfolio Table 92. Molecular Partners Recent Development Table 93. Yooyoung Pharm Company Information Table 94. Yooyoung Pharm Business Overview Table 95. Yooyoung Pharm Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Yooyoung Pharm Hepatocyte Growth Factor Product Portfolio Table 97. Yooyoung Pharm Recent Development Table 98. F-star Company Information Table 99. F-star Business Overview Table 100. F-star Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. F-star Hepatocyte Growth Factor Product Portfolio Table 102. F-star Recent Development Table 103. Galaxy Biotech Company Information Table 104. Galaxy Biotech Business Overview Table 105. Galaxy Biotech Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Galaxy Biotech Hepatocyte Growth Factor Product Portfolio Table 107. Galaxy Biotech Recent Development Table 108. Kringle Pharma Company Information Table 109. Kringle Pharma Business Overview Table 110. Kringle Pharma Hepatocyte Growth Factor Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Kringle Pharma Hepatocyte Growth Factor Product Portfolio Table 112. Kringle Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Hepatocyte Growth Factor Distributors List Table 116. Hepatocyte Growth Factor Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Hepatocyte Growth Factor Product Image Figure 2. Global Hepatocyte Growth Factor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatocyte Growth Factor Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatocyte Growth Factor Sales (2021-2032) & (K Units) Figure 5. Global Hepatocyte Growth Factor Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hepatocyte Growth Factor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Phase III (Ongoing) Image Figure 9. Phase II (Approved) Image Figure 10. Phase II (Ongoing) Image Figure 11. Phase 1 Image Figure 12. Preclinical Image Figure 13. Global Hepatocyte Growth Factor Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hepatocyte Growth Factor Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hepatocyte Growth Factor Sales Market Share by Type (2021-2032) Figure 16. Global Hepatocyte Growth Factor Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Hepatocyte Growth Factor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Hepatocyte Growth Factor Revenue Market Share by Type (2021-2032) Figure 19. Oncology Image Figure 20. Cardiovascular Image Figure 21. Central Nervous System Image Figure 22. Hematological Disorders Image Figure 23. Others Image Figure 24. Global Hepatocyte Growth Factor Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Hepatocyte Growth Factor Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hepatocyte Growth Factor Sales Market Share by Application (2021-2032) Figure 27. Global Hepatocyte Growth Factor Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Hepatocyte Growth Factor Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Hepatocyte Growth Factor Revenue Market Share by Application (2021-2032) Figure 30. North America Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Hepatocyte Growth Factor Sales Market Share by Country (2021-2032) Figure 32. U.S. Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Hepatocyte Growth Factor Sales Market Share by Country (2021-2032) Figure 37. Germany Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Hepatocyte Growth Factor Sales Market Share by Country (2021-2032) Figure 44. China Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Hepatocyte Growth Factor Sales Market Share by Country (2021-2032) Figure 52. Brazil Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Hepatocyte Growth Factor Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Hepatocyte Growth Factor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Hepatocyte Growth Factor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Hepatocyte Growth Factor Revenue (2021-2032) & (US$ Million) Figure 63. North America Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Hepatocyte Growth Factor Revenue (2021-2032) & (US$ Million) Figure 65. Europe Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Hepatocyte Growth Factor Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Hepatocyte Growth Factor Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Hepatocyte Growth Factor Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Hepatocyte Growth Factor Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Phase III (Ongoing)
  • Phase II (Approved)
  • Phase II (Ongoing)
  • Phase 1
  • Preclinical
Applications
  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Hematological Disorders
  • Others
Companies covered
  • ViroMed
  • AnGes MG
  • M3 Biotechnology
  • AVEO Pharmaceuticals
  • Molecular Partners
  • Yooyoung Pharm
  • F-star
  • Galaxy Biotech
  • Kringle Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hepatocyte Growth Factor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hepatocyte Growth Factor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hepatocyte Growth Factor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hepatocyte Growth Factor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hepatocyte Growth Factor Market Dynamics
  1. 2.1 Hepatocyte Growth Factor Industry Trends
  2. 2.2 Hepatocyte Growth Factor Industry Drivers
  3. 2.3 Hepatocyte Growth Factor Industry Opportunities and Challenges
  4. 2.4 Hepatocyte Growth Factor Industry Restraints
3 Hepatocyte Growth Factor Market by Manufacturers
  1. 3.1 Global Hepatocyte Growth Factor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hepatocyte Growth Factor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hepatocyte Growth Factor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hepatocyte Growth Factor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatocyte Growth Factor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hepatocyte Growth Factor Manufacturers, Product Type & Application
  7. 3.7 Global Hepatocyte Growth Factor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatocyte Growth Factor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatocyte Growth Factor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatocyte Growth Factor Tier 1, Tier 2, and Tier 3
4 Hepatocyte Growth Factor Market by Type
  1. 4.1 Hepatocyte Growth Factor Type Introduction
  2. 4.1.1 Phase III (Ongoing)
  3. 4.1.2 Phase II (Approved)
  4. 4.1.3 Phase II (Ongoing)
  5. 4.1.4 Phase 1
  6. 4.1.5 Preclinical
  7. 4.2 Global Hepatocyte Growth Factor Sales by Type
  8. 4.2.1 Global Hepatocyte Growth Factor Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hepatocyte Growth Factor Sales by Type (2021-2032)
  10. 4.2.3 Global Hepatocyte Growth Factor Sales Market Share by Type (2021-2032)
  11. 4.3 Global Hepatocyte Growth Factor Revenue by Type
  12. 4.3.1 Global Hepatocyte Growth Factor Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hepatocyte Growth Factor Revenue by Type (2021-2032)
  14. 4.3.3 Global Hepatocyte Growth Factor Revenue Market Share by Type (2021-2032)
5 Hepatocyte Growth Factor Market by Application
  1. 5.1 Hepatocyte Growth Factor Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiovascular
  4. 5.1.3 Central Nervous System
  5. 5.1.4 Hematological Disorders
  6. 5.1.5 Others
  7. 5.2 Global Hepatocyte Growth Factor Sales by Application
  8. 5.2.1 Global Hepatocyte Growth Factor Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hepatocyte Growth Factor Sales by Application (2021-2032)
  10. 5.2.3 Global Hepatocyte Growth Factor Sales Market Share by Application (2021-2032)
  11. 5.3 Global Hepatocyte Growth Factor Revenue by Application
  12. 5.3.1 Global Hepatocyte Growth Factor Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hepatocyte Growth Factor Revenue by Application (2021-2032)
  14. 5.3.3 Global Hepatocyte Growth Factor Revenue Market Share by Application (2021-2032)
6 Global Hepatocyte Growth Factor Sales by Region
  1. 6.1 Global Hepatocyte Growth Factor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hepatocyte Growth Factor Sales by Region (2021-2032)
  3. 6.2.1 Global Hepatocyte Growth Factor Sales by Region (2021-2026)
  4. 6.2.2 Global Hepatocyte Growth Factor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hepatocyte Growth Factor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hepatocyte Growth Factor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hepatocyte Growth Factor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hepatocyte Growth Factor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hepatocyte Growth Factor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hepatocyte Growth Factor Revenue by Region
  1. 7.1 Global Hepatocyte Growth Factor Revenue by Region
  2. 7.1.1 Global Hepatocyte Growth Factor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hepatocyte Growth Factor Revenue by Region (2021-2026)
  4. 7.1.3 Global Hepatocyte Growth Factor Revenue by Region (2027-2032)
  5. 7.1.4 Global Hepatocyte Growth Factor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hepatocyte Growth Factor Revenue (2021-2032)
  8. 7.2.2 North America Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hepatocyte Growth Factor Revenue (2021-2032)
  11. 7.3.2 Europe Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hepatocyte Growth Factor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hepatocyte Growth Factor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hepatocyte Growth Factor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ViroMed
  2. 8.1.1 ViroMed Company Information
  3. 8.1.2 ViroMed Business Overview
  4. 8.1.3 ViroMed Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ViroMed Hepatocyte Growth Factor Product Portfolio
  6. 8.1.5 ViroMed Recent Developments
  7. 8.2 AnGes MG
  8. 8.2.1 AnGes MG Company Information
  9. 8.2.2 AnGes MG Business Overview
  10. 8.2.3 AnGes MG Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AnGes MG Hepatocyte Growth Factor Product Portfolio
  12. 8.2.5 AnGes MG Recent Developments
  13. 8.3 M3 Biotechnology
  14. 8.3.1 M3 Biotechnology Company Information
  15. 8.3.2 M3 Biotechnology Business Overview
  16. 8.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 M3 Biotechnology Hepatocyte Growth Factor Product Portfolio
  18. 8.3.5 M3 Biotechnology Recent Developments
  19. 8.4 AVEO Pharmaceuticals
  20. 8.4.1 AVEO Pharmaceuticals Company Information
  21. 8.4.2 AVEO Pharmaceuticals Business Overview
  22. 8.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Product Portfolio
  24. 8.4.5 AVEO Pharmaceuticals Recent Developments
  25. 8.5 Molecular Partners
  26. 8.5.1 Molecular Partners Company Information
  27. 8.5.2 Molecular Partners Business Overview
  28. 8.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Molecular Partners Hepatocyte Growth Factor Product Portfolio
  30. 8.5.5 Molecular Partners Recent Developments
  31. 8.6 Yooyoung Pharm
  32. 8.6.1 Yooyoung Pharm Company Information
  33. 8.6.2 Yooyoung Pharm Business Overview
  34. 8.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Yooyoung Pharm Hepatocyte Growth Factor Product Portfolio
  36. 8.6.5 Yooyoung Pharm Recent Developments
  37. 8.7 F-star
  38. 8.7.1 F-star Company Information
  39. 8.7.2 F-star Business Overview
  40. 8.7.3 F-star Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 F-star Hepatocyte Growth Factor Product Portfolio
  42. 8.7.5 F-star Recent Developments
  43. 8.8 Galaxy Biotech
  44. 8.8.1 Galaxy Biotech Company Information
  45. 8.8.2 Galaxy Biotech Business Overview
  46. 8.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Galaxy Biotech Hepatocyte Growth Factor Product Portfolio
  48. 8.8.5 Galaxy Biotech Recent Developments
  49. 8.9 Kringle Pharma
  50. 8.9.1 Kringle Pharma Company Information
  51. 8.9.2 Kringle Pharma Business Overview
  52. 8.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kringle Pharma Hepatocyte Growth Factor Product Portfolio
  54. 8.9.5 Kringle Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hepatocyte Growth Factor Value Chain Analysis
  2. 9.1.1 Hepatocyte Growth Factor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hepatocyte Growth Factor Production Mode & Process
  6. 9.2 Hepatocyte Growth Factor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hepatocyte Growth Factor Distributors
  9. 9.2.3 Hepatocyte Growth Factor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst